Facebook Linkedin RSS Twitter Youtube
Home 2024

T-cells

Streamlining CAR/TCR T-Cell Therapy Manufacturing
Cancer

Streamlining CAR/TCR T-Cell Therapy Manufacturing

Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism
Insights

Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism

Webinar Recap: Modeling the Holistic Journey of Solid Tumor Cell Therapy with Organ-Chips
Cancer

Webinar Recap: Modeling the Holistic Journey of Solid Tumor Cell Therapy with Organ-Chips

Overcoming Viral Vector Risks
Bioprocessing

Overcoming Viral Vector Risks

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show
Cancer

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show

Regulatory T Cell Study in Mice Uncovers “New Rules of The Immune System”
Featured

Regulatory T Cell Study in Mice Uncovers “New Rules of The Immune System”

Checkpoint Therapy Could Be Enhanced by Cutting CD8+ T Cell/Treg Crosstalk
Cancer

Checkpoint Therapy Could Be Enhanced by Cutting CD8+ T Cell/Treg Crosstalk

Shape-Shifting T Cells Signal Activity State
Artificial Intelligence

Shape-Shifting T Cells Signal Activity State

Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform
Bioprocessing

Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform

123...100Page 1 of 100
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.